Filters

Bacillus cereus subsp. cytotoxis Protoheme IX farnesyltransferase 1 (ctaB1)

Bacillus cereus subsp. cytotoxis Protoheme IX farnesyltransferase 1 (ctaB1) size: 1000ug 1835

Price 1835
Size 1000ug
Long name cytotoxis Protoheme IX farnesyltransferase 1 (ctaB1), Recombinant Bacillus cereus subsp
Alternative names Heme B farnesyltransferase 1, Heme O synthase 1, Protoheme IX farnesyltransferase 1, protoheme IX farnesyltransferase, protoheme IX farnesyltransferase
Gene nameN/A
Other gene names ctaB1, Bcer98_1429
General description All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, coli, Protoheme IX farnesyltransferase 1 (ctaB1) is a recombinant protein expressed in E
Product categoryRecombinant Proteins
Expression system coli, E
Available also expressed in: Yeast, E Coli
PurityGreater than 90% (determined by SDS-PAGE)
Form We can custom produce according to your specifications, This item requires custom production and lead time is between 5-9 weeks
Storage Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius
Applications IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA
Description Anthrax has a very high toxin level and is used in Biologic warfare, However 1 is a harmless product, Bacillus Anthracis and Cereus are the most known Bacilli
Gene target cytotoxis Protoheme IX farnesyltransferase 1 (ctaB1), Bacillus cereus subsp
Short name cytotoxis Protoheme IX farnesyltransferase 1 (ctaB1), Bacillus cereus subsp
Alternative name cytotoxis Protoheme IX farnesyltransferase 1 (ctaB1), Bacillus cereus subsp

Similar products

Subscribe to our Newsletter